<DOC>
	<DOCNO>NCT00575016</DOCNO>
	<brief_summary>The purpose study explore effectiveness safety several dos botulinum toxin type A treating overactive bladder patient spinal cord injury .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treatment Neurogenic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Urinary incontinence result neurogenic overactive bladder due spinal cord injury Inadequate response anticholinergic medication use treat overactive bladder History evidence pelvic urologic abnormality Previous current diagnosis bladder prostate cancer Urinary tract infection time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>